Selecting appropriate inhalers based on individual characteristics and shared decision-making is crucial for optimizing care for patients with COPD. Jeffrey D. Dunn ...
Inhalers Single-inhaler triple therapy is associated with a favorable benefit-risk profile compared with dual therapy for patients with symptomatic COPD and a history of exacerbations. Single-inhaler ...
PARMA, Italy, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Today, Chiesi Farmaceutici, an international research-focused healthcare group (Chiesi Group), announced the results of two studies published in The ...
Among patients with chronic obstructive pulmonary disease who received prior treatment with multiple-inhaler triple therapy, single-inhaler triple therapy was effective in improving health status and ...
(HealthDay News) — For patients with chronic obstructive pulmonary disease (COPD), once-daily single-inhaler triple therapy is better for lung function and health-related quality of life than inhaled ...
Please provide your email address to receive an email when new articles are posted on . Inhaled corticosteroids were associated with lower odds for mortality in patients with COPD. An eosinophil count ...
Results showed budesonide/glycopyrronium/formoterol fumarate 320/28.8/9.6μg met all primary endpoints in both KALOS and LOGOS. Topline data were announced from two ...
Inhaler technique informs health care outcomes in COPD management and should be a primary focus in patient education priorities. Jeffrey D. Dunn, PharmD, MBA: [Let’s talk about] patient perspective ...
PHILADELPHIA, Pennsylvania — A simple handheld training device doubles the likelihood that patients with asthma will achieve the correct inspiratory flow when using their medication inhalers. After ...
Clinical worsening also occurred less frequently with treprostinil ...
I really didn't see the death of short-acting beta-agonists (SABAs) coming. Sure, I'd read the SYGMA trials, [1,2] and yes, I was aware of lobbying from the "other side of the pond" (Europe). [3] So I ...
Asthma patients in South Carolina are being confronted with a critical development: the departure of the widely used inhaler, Flovent, from pharmacy shelves. This shift, initiated by manufacturer GSK, ...